{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:42:12Z","timestamp":1792172532243,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05084-z","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:45:26Z","timestamp":1779288326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune microenvironment and its influence on CAR-T treatment outcomes in B-NHL"],"prefix":"10.1007","volume":"17","author":[{"given":"Danyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"1","key":"5084_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","volume":"50","author":"S Li","year":"2018","unstructured":"Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50(1):74\u201387.","journal-title":"Pathology"},{"issue":"11","key":"5084_CR2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/a-2160-5353","volume":"149","author":"JC Hellmuth","year":"2024","unstructured":"Hellmuth JC, Koch R, Weigert O. Targeted therapies in the management of malignant lymphoma - is the end of conventional chemotherapy near? Dtsch Med Wochenschr. 2024;149(11):621\u20139.","journal-title":"Dtsch Med Wochenschr"},{"key":"5084_CR3","doi-asserted-by":"publisher","unstructured":"Canichella, M., & de Fabritiis, P. (2025). CAR-T Therapy Beyond B-Cell Hematological Malignancies. Cells, 14(1), 41. https:\/\/doi.org\/10.3390\/cells14010041","DOI":"10.3390\/cells14010041"},{"issue":"5","key":"5084_CR4","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00277-024-05677-0","volume":"103","author":"S Mercadal","year":"2024","unstructured":"Mercadal S, et al. Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature. Ann Hematol. 2024;103(5):1717\u201327.","journal-title":"Ann Hematol"},{"issue":"36","key":"5084_CR5","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1038\/onc.2014.403","volume":"34","author":"KH Shain","year":"2015","unstructured":"Shain KH, Dalton WS, Tao J. The tumor microenvironment shapes hallmarks of mature B-cell malignancies. Oncogene. 2015;34(36):4673\u201382.","journal-title":"Oncogene"},{"issue":"5","key":"5084_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00432-024-05777-4","volume":"150","author":"R Huang","year":"2024","unstructured":"Huang R, Kang T, Chen S. The role of tumor-associated macrophages in tumor immune evasion. J Cancer Res Clin Oncol. 2024;150(5):238.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"18","key":"5084_CR7","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1182\/bloodadvances.2018019919","volume":"2","author":"H Arima","year":"2018","unstructured":"Arima H, et al. B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33. Blood Adv. 2018;2(18):2282\u201395.","journal-title":"Blood Adv"},{"key":"5084_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fonc.2018.00086","volume":"8","author":"JA Seidel","year":"2018","unstructured":"Seidel JA, Otsuka A, Kabashima K. Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations. Front Oncol. 2018;8:86.","journal-title":"Front Oncol"},{"issue":"11","key":"5084_CR9","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337.","journal-title":"Nat Med"},{"issue":"3","key":"5084_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.bbamcr.2015.11.003","volume":"1863","author":"NS Nicholas","year":"2016","unstructured":"Nicholas NS, Apollonio B, Ramsay AG. Tumor microenvironment (TME)-driven immune suppression in B cell malignancy. Biochim Biophys Acta. 2016;1863(3):471\u201382.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"5084_CR11","first-page":"91","volume":"29","author":"F Bao","year":"2021","unstructured":"Bao F, Zhu WW, Wang MX, Ke J. The relationship between reducing of peripheral blood treg in primary diffuse large B-cell lymphoma patients and poor prognosis. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021;29(1):91\u20137.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"9","key":"5084_CR12","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00262-020-02591-y","volume":"69","author":"M Dehghani","year":"2020","unstructured":"Dehghani M, et al. Aberrant peripheral blood CD4(+) CD25(+) FOXP3(+) regulatory T cells\/T helper-17 number is associated with the outcome of patients with lymphoma. Cancer Immunol Immunother. 2020;69(9):1917\u201328.","journal-title":"Cancer Immunol Immunother"},{"key":"5084_CR13","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez-Cortegana, C., Palaz\u00f3n-Carri\u00f3n, N., Martin Garcia-Sancho, A., Nogales-Fernandez, E., Carnicero-Gonz\u00e1lez, F., R\u00edos-Herranz, E., de la Cruz-Vicente, F., Rodr\u00edguez-Garc\u00eda, G., Fern\u00e1ndez-\u00c1lvarez, R., Rueda Dominguez, A., Casanova-Espinosa, M., Mart\u00ednez-Banaclocha, N., Gum\u00e0-Padr\u00f2, J., G\u00f3mez-Codina, J., Labrador, J., Salar-Silvestre, A., Rodriguez-Abreu, D., Galvez-Carvajal, L., Provencio, M., S\u00e1nchez-Beato, M., \u2026 Spanish Lymphoma Oncology Group (GOTEL) and the Spanish Group for Immunobiotherapy of Cancer (G\u00c9TICA) (2021). Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory\/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial. Journal for immunotherapy of cancer, 9(6), e002323. https:\/\/doi.org\/10.1136\/jitc-2020-002323","DOI":"10.1136\/jitc-2020-002323"},{"issue":"1","key":"5084_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12967-022-03588-0","volume":"20","author":"X Su","year":"2022","unstructured":"Su X, et al. Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape. J Transl Med. 2022;20(1):378.","journal-title":"J Transl Med"},{"key":"5084_CR15","doi-asserted-by":"publisher","first-page":"107662","DOI":"10.1016\/j.intimp.2021.107662","volume":"96","author":"W Zhong","year":"2021","unstructured":"Zhong W, et al. High levels of Tim-3(+)Foxp3(+)Treg cells in the tumor microenvironment is a prognostic indicator of poor survival of diffuse large B cell lymphoma patients. Int Immunopharmacol. 2021;96:107662.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"5084_CR16","doi-asserted-by":"publisher","first-page":"e13352","DOI":"10.1111\/sji.13352","volume":"99","author":"L Pu","year":"2024","unstructured":"Pu L, et al. Predictive model for CAR-T cell therapy success in patients with relapsed\/refractory B-cell acute lymphoblastic leukaemia. Scand J Immunol. 2024;99(4):e13352.","journal-title":"Scand J Immunol"},{"key":"5084_CR17","doi-asserted-by":"publisher","first-page":"1566363","DOI":"10.3389\/fmolb.2025.1566363","volume":"12","author":"C Yue","year":"2025","unstructured":"Yue C, et al. TNFAIP8L3 regulation of the TGF-beta signaling pathway affects the proportion of macrophages during tumor antigen presentation and affects the prognosis of ovarian cancer. Front Mol Biosci. 2025;12:1566363.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"5084_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00262-006-0194-y","volume":"56","author":"KL Knutson","year":"2007","unstructured":"Knutson KL, Disis ML, Salazar LG. CD4 regulatory T cells in human cancer pathogenesis. Cancer Immunol Immunother. 2007;56(3):271\u201385.","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"5084_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1182\/bloodadvances.2016000885","volume":"1","author":"S Nakayama","year":"2017","unstructured":"Nakayama S, et al. Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified. Blood Adv. 2017;1(8):486\u201393.","journal-title":"Blood Adv"},{"issue":"2","key":"5084_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/ejh.12144","volume":"91","author":"M Glowala-Kosinska","year":"2013","unstructured":"Glowala-Kosinska M, et al. Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma. Eur J Haematol. 2013;91(2):122\u20138.","journal-title":"Eur J Haematol"},{"key":"5084_CR21","doi-asserted-by":"publisher","first-page":"1532460","DOI":"10.3389\/fimmu.2025.1532460","volume":"16","author":"D Li","year":"2025","unstructured":"Li D, et al. Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory\/relapsed B-cell lymphoma: a single-arm clinical study. Front Immunol. 2025;16:1532460.","journal-title":"Front Immunol"},{"key":"5084_CR22","doi-asserted-by":"publisher","first-page":"1566938","DOI":"10.3389\/fonc.2025.1566938","volume":"15","author":"R Liu","year":"2025","unstructured":"Liu R, et al. CAR T- cell therapy provides an opportunity for further consolidation treatment for relapsed or refractory adult Burkitt lymphoma patients. Front Oncol. 2025;15:1566938.","journal-title":"Front Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05084-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05084-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05084-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:21:44Z","timestamp":1783992104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05084-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5084"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05084-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving humans were approved by The Ethics Committee at Beijing Gobroad Hospital in Beijing. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent was obtained from all participants or their families prior to obtaining the samples.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All patients participated in the clinical trial using the CAR-T cell product from Shanghai Yake Biotechnology Co., Ltd. in China, with the clinical registration number ChiCTR2100055062.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"1019"}}